These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 24846237)
1. Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components. Agouni A; Andriantsitohaina R; Martinez MC Curr Vasc Pharmacol; 2014 May; 12(3):483-92. PubMed ID: 24846237 [TBL] [Abstract][Full Text] [Related]
2. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Berezin A; Zulli A; Kerrigan S; Petrovic D; Kruzliak P Clin Biochem; 2015 Jun; 48(9):562-8. PubMed ID: 25697107 [TBL] [Abstract][Full Text] [Related]
3. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Meziani F; Tesse A; Andriantsitohaina R Pharmacol Rep; 2008; 60(1):75-84. PubMed ID: 18276988 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes. Benameur T; Osman A; Parray A; Ait Hssain A; Munusamy S; Agouni A Oxid Med Cell Longev; 2019; 2019():6475187. PubMed ID: 30915196 [TBL] [Abstract][Full Text] [Related]
5. Circulating Microparticles Are Elevated in Treated HIV -1 Infection and Are Deleterious to Endothelial Cell Function. Hijmans JG; Stockelman KA; Garcia V; Levy MV; Brewster LM; Bammert TD; Greiner JJ; Stauffer BL; Connick E; DeSouza CA J Am Heart Assoc; 2019 Feb; 8(4):e011134. PubMed ID: 30779672 [TBL] [Abstract][Full Text] [Related]
6. Microparticles as potential biomarkers of cardiovascular disease. França CN; Izar MC; Amaral JB; Tegani DM; Fonseca FA Arq Bras Cardiol; 2015 Feb; 104(2):169-74. PubMed ID: 25626759 [TBL] [Abstract][Full Text] [Related]
7. Microparticles (Exosomes) and Atherosclerosis. Chen YT; Yuan HX; Ou ZJ; Ou JS Curr Atheroscler Rep; 2020 May; 22(6):23. PubMed ID: 32468443 [TBL] [Abstract][Full Text] [Related]
14. Microparticles: a component of various diseases. Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Zhang J Rev Cardiovasc Med; 2022 Feb; 23(2):73. PubMed ID: 35229564 [TBL] [Abstract][Full Text] [Related]
16. The many faces of endothelial microparticles. Dignat-George F; Boulanger CM Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065 [TBL] [Abstract][Full Text] [Related]
17. Microparticles, vascular function and hypertension. Boulanger CM Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854 [TBL] [Abstract][Full Text] [Related]
19. Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review. Deng F; Wang S; Zhang L Biomed Res Int; 2016; 2016():9802026. PubMed ID: 27803933 [TBL] [Abstract][Full Text] [Related]
20. Microparticles as new markers of cardiovascular risk in diabetes and beyond. Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]